找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways; Yosef Yarden,Moshe Elkabets Book 2018

[复制链接]
楼主: Ejaculation
发表于 2025-3-26 21:30:31 | 显示全部楼层
发表于 2025-3-27 01:48:29 | 显示全部楼层
Resistance Mechanisms to Cyclin-Dependent Kinase Inhibitors, cycle deregulation is a hallmark of cancer, and CDKs have long been considered attractive targets for anti-cancer agents. After initial failures of pan-CDKi in clinical trials, two highly specific CDK4/6 inhibitors, palbociclib and ribociclib, are now FDA-approved in hormone receptor-positive breas
发表于 2025-3-27 07:27:20 | 显示全部楼层
发表于 2025-3-27 11:04:26 | 显示全部楼层
发表于 2025-3-27 16:57:06 | 显示全部楼层
Mechanisms of Action and Resistance of Trastuzumab in Breast Cancer,wever, resistance to trastuzumab, either . or acquired resistance, presents a major clinical challenge. Here, we summarize the mechanisms of action and resistance of trastuzumab in breast cancer and discuss potential strategies to overcome resistance.
发表于 2025-3-27 20:57:56 | 显示全部楼层
发表于 2025-3-28 01:22:08 | 显示全部楼层
a geometric structure or a long-range interaction. The farther spin interactions than the nearest sites stem from a coupling with other degrees of freedom in many realistic materials. Among them, the spin-lattice interaction has a large contribution for the effective spin interaction, and the spin-P
发表于 2025-3-28 03:36:23 | 显示全部楼层
发表于 2025-3-28 09:34:11 | 显示全部楼层
发表于 2025-3-28 12:54:49 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-23 05:59
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表